Pfizer Financial News

13.10 / 22:02

COST Provident Target Pfizer vaccine Pfizer slashes 2023 revenue forecast on lower COVID sales; will cut expenses, jobs

(Reuters) -Pfizer on Friday slashed its full-year revenue forecast by around 13% and launched a $3.5 billion cost cutting program due to lower-than-expected sales of its COVID-19 vaccine and treatment.

11.10 / 13:49

Career Compilation Mobile Citigroup Pfizer Seagen Department Petrie joins Wall Street powerhouses on Exxon-Pioneer megadeal

By Anirban Sen and David French

08.10 / 15:35

Citi Aware Pfizer pop 2020 reports Travis Kelce's Net Worth—He's Even More Popular Thanks to Taylor Swift Rumors

Kansas City Chiefs tight end Travis Kelce has become even more popular recently thanks to his rumored relationship with pop superstar Taylor Swift. After Swift was seen cheering Kelce on at a Chiefs game at Kansas City's Arrowhead Stadium on Sept. 24, sales of Kelce's jersey jumped nearly 400% on sportswear and fan merchandise site Fanatics, according to The Associated Press.

05.10 / 10:53

UPS NIFTY Pfizer SENSEX index Stock market update: Nifty Pharma index falls 0.3%

Shares of Pfizer Ltd.(up 1.11 per cent), Sanofi India Ltd.(up 0.98 per cent), Laurus Labs Ltd.(up 0.88 per cent), Ipca Laboratories Ltd.(up 0.59 per cent) and Zydus Lifesciences Ltd.(up 0.26 per cent) ended the day as top gainers in the pack. On the other hand, Glenmark Pharmaceuticals Ltd.(down 1.72 per cent), Granules India Ltd.(down 1.44 per cent), GlaxoSmithKline Pharmaceuticals Ltd.(down 1.3 per cent), Torrent Pharmaceuticals Ltd.(down 0.72 per cent) and Aurobindo Pharma Ltd.(down 0.57 per cent) finished as the top losers of the day.

05.10 / 04:47

UPS NIFTY Pfizer SENSEX reports index Stock market update: Nifty Pharma index flat 0.0% in an upbeat market

Dr. Reddy's Laboratories Ltd.(up 0.79 per cent), Zydus Lifesciences Ltd.(up 0.67 per cent), Pfizer Ltd.(up 0.64 per cent), Alkem Laboratories Ltd.(up 0.59 per cent) and Abbott India Ltd.(up 0.43 per cent) were among the top gainers.

04.10 / 18:21

Merck Pfizer show hospital Department recommendations US plans shift of Merck COVID treatment to commercial market

By Michael Erman

04.10 / 07:27

Moderna Pfizer Novavax vaccine prevention infection fall Option US adds another option for fall COVID vaccination with updated Novavax shots

U.S. regulators have added another option for fall COVID-19 vaccination, updated shots made by Novavax

04.10 / 04:53

SUN NIFTY Pfizer SENSEX reports index Stock market update: Nifty Pharma index falls 0.76% in a weak market

Natco Pharma Ltd.(up 0.66 per cent), Dr. Reddy's Laboratories Ltd.(up 0.55 per cent), Granules India Ltd.(up 0.54 per cent) and Pfizer Ltd.(up 0.41 per cent) were among the top gainers.

03.10 / 10:37

BLOCK awards Pfizer Immunic vaccine 2020 medicines Covid vaccine scientists awarded Nobel Prize

We don’t support this browser anymore. This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

02.10 / 18:55

Moderna Pfizer BioNTech Coronavirus vaccine Virus Years of research laid the groundwork for speedy COVID-19 shots

The Nobel Prize in Medicine has been awarded to two scientists whose work led to mRNA vaccines against COVID-19

27.09 / 10:01

Manufacturing Mobile Pfizer Experts performer recommendations KPIT Technologies and 4 other midcap stocks surpass 100-day SMA

midcap stocks demonstrated their resilience by surpassing their 100-day SMA. Let's explore the performance of these stocks. (Data Source: StockEdge) 1. Astral Astral Limited is a leading manufacturer of pipes and fittings for plumbing and agricultural applications.

27.09 / 05:23

UPS NIFTY Pfizer reports index Stock market update: Nifty Pharma index advances 0.87% in a weak market

Cipla Ltd.(up 1.82 per cent), Granules India Ltd.(up 1.61 per cent), Lupin Ltd.(up 1.56 per cent), Gland Pharma Ltd.(up 1.49 per cent) and Dr. Reddy's Laboratories Ltd.(up 1.25 per cent) were among the top gainers.

26.09 / 05:29

UPS NIFTY Pfizer reports index Stock market update: Nifty Pharma index falls 0.11% in a weak market

Natco Pharma Ltd.(up 3.09 per cent), Dr.

23.09 / 02:43

Pfizer vaccine Virus Pregnancy recommendations prevention infection Option RSV vaccine recommended during pregnancy as a second option to protect newborns

U.S. health officials are recommending RSV vaccinations for moms-to-be as a second option to protect newborns

22.09 / 10:53

Lowe's NIFTY Pfizer SENSEX Vodafone index Stock market update: Nifty Pharma index falls 1.55%

Shares of Granules India Ltd.(up 4.2 per cent), Pfizer Ltd.(up 0.67 per cent) and GlaxoSmithKline Pharmaceuticals Ltd.(up 0.3 per cent) ended the day as top gainers in the pack. On the other hand, Zydus Lifesciences Ltd.(down 3.25 per cent), Glenmark Pharmaceuticals Ltd.(down 3.0 per cent), Alkem Laboratories Ltd.(down 2.77 per cent), Dr.

22.09 / 04:55

Lowe's NIFTY Pfizer SENSEX reports index Stock market update: Nifty Pharma index falls 1.8% in a weak market

Granules India Ltd.(up 0.15 per cent), GlaxoSmithKline Pharmaceuticals Ltd.(up 0.06 per cent) and Pfizer Ltd.(up 0.02 per cent) were among the top gainers. Glenmark Pharmaceuticals Ltd.(down 5.38 per cent), Lupin Ltd.(down 2.99 per cent), Aurobindo Pharma Ltd.(down 2.71 per cent), Dr.

19.09 / 17:31

Lowe's Platform Pfizer show performer Pfizer Nears Pre-Pandemic Levels: Is the Stock Ready to Bottom Out?

After experiencing a surge during the pandemic, Pfizer (NYSE:PFE) entered a long-term downtrend in December 2021. The stock showed signs of a potential recovery in the October-December period last year. However, it struggled to fend off the persistent selling pressure, ultimately resulting in the price returning close to pre-pandemic levels.

19.09 / 09:29

UPS Progressive Strategy Pfizer country Torrent Pharmaceutical in talks with Apollo to borrow up to $1 billion for Cipla bid

MUMBAI/NEW DELHI : India's Torrent Pharmaceutical is in preliminary talks with Apollo Global Management to secure a loan of up to $1 billion to help fund a planned bid for Cipla, two people briefed on the discussions said. Torrent is hoping to secure roughly $3 billion to $4 billion in financing for the bid for its much bigger rival, they said. Bernstein analysts have estimated that a deal for about 60% of India's No.

18.09 / 11:39

UPS Pfizer Colgate-Palmolive star Olectra Greentech, Rajesh Exports among 10 stocks with RSI trending up

Relative Strength Index (RSI). On September 15, Friday, StockEdge highlighted 23 stocks with RSI trending up, indicating potential bullish momentum. In this article, we'll demystify RSI and explore 10 of these promising stocks. The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements.

18.09 / 10:15

UPS Reuters Pfizer country Torrent Pharma in talks with CVC, Bain Capital to raise funds for Cipla buyout

Torrent Pharmaceuticals is in talks with private equity funds CVC Capital Partners and Bain Capital. The Indian pharmaceutical is planning to raise up to $1.5 billion to bid for Cipla, reported Reuters citing sources familiar with the matter. Torrent and Blackstone are among those interested to acquire a stake in Cipla, India's third-biggest drugmaker by sales, in what could be the largest pharma deal in India ever.

15.09 / 17:43

COST Provident Pfizer J&J country Big Pharma's Johnson & Johnson under investigation in South Africa over 'excessive' drug prices

U.S.-based pharmaceuticals company Johnson & Johnson is being investigated in South Africa for allegedly charging “excessive” prices for a key tuberculosis drug

frequently asked questions about Pfizer

What is Pfizer and why is it relevant?

Pfizer is a significant category that draws public attention. On our site, we regularly publish updates related to this subject.

Where can I find the latest updates on Pfizer?

All recent news about Pfizer can be found in the special selection. We publish information regularly.

How can I verify the accuracy of information on Pfizer?

We consult with professionals to ensure that the information about Pfizer is well-supported and informative for our readers.